This report on the I-SPY 2 Clinical Trial was provided to the Foundation for NIH courtesy of NBC News 4 (WRC-TV) in Washington DC.

The highly anticipated clinical trial is a groundbreaking public-private collaboration of the Foundation for NIH's The Biomarkers Consortium, combining personalized medicine with a novel trial design to develop potentially life saving new breast cancer drugs.